Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, long-term illness that affects many body systems. People with ME/CFS are often not able to do their usual activities. At times, ME/CFS may confine them to bed. People with ME/CFS have severe fatigue and sleep problems. ME/CFS may get worse after people with the illness try to do as much as they want or need to do. This symptom is known as post-exertional malaise (PEM). Other symptoms can include problems with thinking and concentrating, pain, and dizziness.

According to an Institute of Medicine (IOM) report external iconpublished in 2015, an estimated 836,000 to 2.5 million Americans suffer from ME/CFS, but most of them have not been diagnosed.

ME/CFS and COVID-19: What we know

CDC is working with partners and stakeholders to better understand the long-term effects of coronavirus disease 2019 (COVID-19) and how it affects people with ME/CFS. Currently, there are limited data and information about the long-term effects of COVID-19. A recent MMWR report found that COVID-19 can result in prolonged illness, even among adults without underlying chronic medical conditions. Studies are planned to identify whether some people with delayed recovery develop an ME/CFS-like illness.

It is especially important for people at increased risk of severe illness from COVID-19 to protect themselves from getting COVID-19. Currently, ME/CFS is not included in the list of medical conditions that increase risk of severe illness from COVID-19. However, people with ME/CFS might consider taking extra precautions to reduce their risk of getting COVID-19 by following these recommendations. We are learning more about COVID-19 every day, and as new information becomes available, CDC will continue to update our recommendations and guidance.